| Financial Year |
March 31 2023 |
| Monetary Funds |
117,921,010.83 |
| Held-for-trading Financial Assets |
60,716,769.44 |
| Notes Receivable |
10,995,369.24 |
| Accounts Receivable |
265,106,953.16 |
| Advances to Suppliers |
5,106,262.58 |
| Other Receivables |
30,787,915.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,932,577.54 |
| Dividend Receivable |
-- |
| Inventories |
46,265,938.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,756,573.49 |
| Total Current Assets |
1,073,026,780.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
126,514,663.56 |
| Long-term Equity Investment |
34,893,488.74 |
| Investment Properties |
-- |
| Fixed Assetes |
149,438,283.90 |
| Under-construction Projects |
4,507,587.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
75,981,835.73 |
| R&D expenses |
-- |
| Goodwill |
57,649.81 |
| Long-Term Deferred and Prepaid Expenses |
2,878,325.27 |
| Deferred Income Tax Assets |
21,856,700.94 |
| Other Non-Current Assets |
241,519.00 |
| Sub-Total of Non-Current Assets |
423,377,697.98 |
| Total Assets |
1,496,404,478.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
41,335,080.21 |
| Accounts Payable |
343,085,965.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,353,465.60 |
| Taxes Payable |
11,852,092.34 |
| Interest Payable |
285,919.46 |
| Dividend Payable |
-- |
| Other payables |
14,141,321.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,879,436.87 |
| Other Current Liabilities |
59,429,844.64 |
| Sub-Total of Current Liabilities |
496,965,273.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,902,229.94 |
| Deferred Income Tax Liabilities |
5,097,229.70 |
| Other Non-Current Liabilities |
600,000.00 |
| Sub-Total of Non-Current Liabilities |
11,724,512.22 |
| Total Liabilities |
508,689,785.91 |
| Paid-In Capital(Or Share Stock) |
99,094,000.00 |
| Capital Surplus |
465,949,413.18 |
| Surplus Reserve |
38,399,881.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
359,365,199.94 |
| Minority Stockholder's Interest |
24,907,074.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
962,807,617.63 |
| Owner's Equity（Stockholder's Equity） |
987,714,692.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,496,404,478.05 |
